"10.1371_journal.pone.0009540","plos one","2010-03-04T00:00:00Z","Mark R Sommerfeld; Günter Müller; Georg Tschank; Gerhard Seipke; Paul Habermann; Roland Kurrle; Norbert Tennagels","Research and Development TD Metabolism, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany; Process Development Biotechnology, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany","Conceived and designed the experiments: MRS GM GT NT. Performed the experiments: MRS GM GT NT. Analyzed the data: MRS GM GT NT. Contributed reagents/materials/analysis tools: GS PH. Wrote the paper: MRS GM GT NT. Revised the manuscript for important intellectual content: RK.","All authors are employed by Sanofi-Aventis, the manufacturer of the described insulin glargine at the time of the study. NT and GT hold shares in Sanofi-Aventis. Insulin Glargine is covered by claims of EP 0 368 187 B1 (filed on 06.11.1989; inventor: Dr. Michael Doerschug, an employee of Hoechst AG at the time of filing; current patent holder: Sanofi-Aventis Deutschland GmbH, a legal successor of Hoechst AG) and corresponding patents.","2010","03","Mark R Sommerfeld","MRS",7,TRUE,4,4,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
